AOD-9604, or Advanced Obesity Drug 9604, is a peptide fragment derived from human growth hormone
When paired with TB-500s systemic tissue-rebuilding capacity, this duo becomes a full-spectrum recovery system for athletes, post-operative patients, and individuals facing chronic inflammation or injury
Its deficiency can lead to changes in gene expression that might predispose individuals to both autoimmunity and increased intestinal permeability[7]
Keatings lab is also designing peptides that could interfere with other relatives of Mcl-1, including one called Bfl-1, which has been less studied than the other members of the family but is also involved in blocking apoptosis
Rodent studies suggest BPC-157 may enhance healing of muscle, tendon, ligament, and nerve injuries while also reducing inflammation, but clinical evidence in humans remains limited to small, uncontrolled observations
Research has explored the interaction of these peptides with growth factors and cellular repair signaling systems in controlled laboratory environments